Planning Clinical Trials: Targeting Patients and Study Sites

Targeting is the cornerstone of any effective marketing communications. Targeting the appropriate patients and study sites vastly improves the timeliness and efficiency of any pharmaceutical clinical trial. Pharmaceutical companies can use the information in this document to make necessary adjustments to the study protocol and finish trials in a timely manner. This 28-page document details the way top pharmaceutical companies identifiy, profile, review, and select investigators, patients, and study sites that are well-matched with the goals of the study.

Key Topics

• leveraging marketing and recruitment expertise for trial planning
• recruitment of the right amount and types of patients
• reaching and securing patients
• defining site selection criteria
• use of diverse sources (internal, external, and publicity generated contacts) in site identification

• Select contract organizations based on their marketing and recruitment expertise in a study’s given therapeutic area to supplement company capabilities.
  *One company outsources studies that are large, have high visibility, and need to be done quickly. It has plans to bring more studies in-house with a team of internal monitors.
• Apply market research techniques to analyze trends with the targeted patient population to predict and plan for patient recruitment.
  *One patient recruitment organization recognizes that some factors that impact a site’s ability to recruit may have nothing to do with the site itself but rather with external market conditions in the site’s location. Therefore, the company has developed a macro-determinator tool to look at areas such as the physicians per capita, cost to advertise, and number of newspapers in the area.
• Apply market research techniques to analyze trends with the targeted patient population to predict and plan for patient recruitment.
  *Having three primary ways to identify study sites for participation in its clinical trials, one company focuses on therapeutic networks, an internal database of preferred providers and its sales force.
  

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.